NEW YORK--(BUSINESS WIRE)--Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that Pharmaxis Ltd is implementing Medidata Rave as its platform to conduct future clinical trials in the therapeutic areas of respiratory and autoimmune diseases. Medidata Rave was chosen by Pharmaxis from a group of eight vendors as the system to manage its Phase II-III clinical trials throughout Australia, the United States and the United Kingdom.
